Hantz Financial Services Inc. Has $271,000 Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Hantz Financial Services Inc. cut its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 8.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 181 shares of the medical instruments supplier’s stock after selling 17 shares during the period. Hantz Financial Services Inc.’s holdings in Mettler-Toledo International were worth $271,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. PineStone Asset Management Inc. raised its holdings in shares of Mettler-Toledo International by 127.4% in the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after purchasing an additional 145,453 shares during the last quarter. Loomis Sayles & Co. L P increased its stake in Mettler-Toledo International by 1.8% in the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock valued at $314,790,000 after buying an additional 3,644 shares during the last quarter. TD Asset Management Inc lifted its position in Mettler-Toledo International by 1.9% during the 2nd quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock worth $219,767,000 after buying an additional 2,866 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Mettler-Toledo International by 32.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock worth $199,777,000 after buying an additional 35,048 shares in the last quarter. Finally, International Assets Investment Management LLC boosted its stake in shares of Mettler-Toledo International by 149,870.0% during the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after buying an additional 89,922 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.94% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Evercore ISI upped their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. boosted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Stifel Nicolaus cut their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Finally, Wells Fargo & Company cut their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $1,338.75.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,260.84 on Tuesday. The company has a market cap of $26.61 billion, a P/E ratio of 33.99, a P/E/G ratio of 4.13 and a beta of 1.16. The firm’s fifty day moving average price is $1,342.27 and its two-hundred day moving average price is $1,390.47. Mettler-Toledo International Inc. has a one year low of $1,068.33 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. As a group, equities research analysts expect that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.